Matthew Langer

Senior Counsel
Full contact info

As an inventor and former scientist, it gives me great pride and satisfaction to partner with my clients to help them protect and commercialize their ground-breaking innovations.



Black and white film photography


Unilever Acquires Hair Wellness Brand Nutrafol

June 1, 2022

Cooley advised Nutrafol, a leading provider of hair wellness products, on its agreement to sell a majority stake in the company to Unilever. Partner Kevin Cooper led the Cooley team advising Nutrafol on the transaction, and partner Stephane Levy has acted as longtime corporate counsel to the company. Nutrafol is backed by Unilever Ventures and consumer-focused private equity firm L Catterton.

Read more

Related contacts

Kevin Cooper
Partner, New York
Stephane Levy
Partner, New York
Zachary Sonenshine
Associate, New York
Natalie D. Vernon
Associate, Colorado
James Lin
Associate, New York
Ariel Rom
Partner, New York
Daniel Chao
Associate, New York
David Dalton
Associate, Los Angeles Santa Monica
Jessica Winn
Associate, Boston
Bomin Kim
Associate, New York
Matthew Langer
Senior Counsel , New York
Danielle Joe
Associate, Washington DC
John Paul Oleksiuk
Partner, New York
Nicollette R. Kirby
Associate, Washington DC
Andrew Bae
Associate, Washington DC
Len Jacoby
Partner, New York
Zimu Yang
Associate, Washington DC
Lei Shen
Partner, Chicago
Grace Hunter
Associate, Washington DC
Jonathan Rivinus
Partner, Colorado
Randy Sabett
Special Counsel, Washington DC
Winda Fung
Associate, Los Angeles Santa Monica
Patrick Flanagan
Partner, New York
Geoffrey Spolyar
Partner, Boston
Megan Donohue
Partner, San Diego
Steven A. Zuckerman
Associate, New York
Sonia Nath
Partner, Washington DC
Veronica Caba
Paralegal Specialist, New York
Patricia Myers
Paralegal Specialist, Colorado

Manage the global patent portfolio of Usher III Initiative

June 23, 2016

Cooley manages the global patent portfolio of Usher III Initiative, Inc., a research consortium of leading retinal and cochlear specialists established to develop treatments for Usher Syndrome Type III.  Usher Syndrome is a genetic disorder that causes progressive hearing and vision loss and affects less than 0.01% of the population worldwide. Cooley’s work has resulted in the issuance of US and foreign patents covering small-molecule therapeutics showing promise as drugs useful for treating Usher Syndrome Type III.

Related contacts

Matthew Langer
Senior Counsel , New York
Asako Kubota
Associate, Washington DC

Rankings & accolades

Legal 500: Top Lawyer for Patent Prosecution

LMG Life Sciences: Life Science Star

Managing Intellectual Property: IP Star

Euromoney: Patent Law

New York Super Lawyers: Intellectual Property

Langer is someone with business skills to go along with his patent prosecution <div></div>skills.

LMG Life Sciences